These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 38608371)
1. Targeting notch-related lncRNAs in cancer: Insights into molecular regulation and therapeutic potential. Siddique R; Gupta G; Mgm J; Kumar A; Kaur H; Ariffin IA; Pramanik A; Almalki WH; Ali H; Shahwan M; Patel N; Murari K; Mishra R; Thapa R; Bhat AA Pathol Res Pract; 2024 May; 257():155282. PubMed ID: 38608371 [TBL] [Abstract][Full Text] [Related]
2. Interaction of Long Noncoding RNAs and Notch Signaling: Implications for Tissue Homeostasis Loss. Salviano-Silva A; Berti FCB; Lobo-Alves SC; de Araujo-Souza PS; Boldt ABW; Malheiros D Adv Exp Med Biol; 2020; 1227():107-129. PubMed ID: 32072502 [TBL] [Abstract][Full Text] [Related]
3. Crosstalk between the Notch signaling pathway and long non-coding RNAs. Reicher A; Foßelteder J; Kwong LN; Pichler M Cancer Lett; 2018 Apr; 420():91-96. PubMed ID: 29409809 [TBL] [Abstract][Full Text] [Related]
4. The interaction between miRNAs/lncRNAs and Notch pathway in human disorders. Ghafouri-Fard S; Glassy MC; Abak A; Hussen BM; Niazi V; Taheri M Biomed Pharmacother; 2021 Jun; 138():111496. PubMed ID: 33743335 [TBL] [Abstract][Full Text] [Related]
5. Connecting the dots: LncRNAs in the KRAS pathway and cancer. Maqbool M; Hussain MS; Bisht AS; Kumari A; Kamran A; Sultana A; Kumar R; Khan Y; Gupta G Pathol Res Pract; 2024 Oct; 262():155570. PubMed ID: 39226802 [TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance. Hashemi M; Hasani S; Hajimazdarany S; Mirmazloomi SR; Makvandy S; Zabihi A; Goldoost Y; Gholinia N; Kakavand A; Tavakolpournegari A; Salimimoghadam S; Nabavi N; Zarrabi A; Taheriazam A; Entezari M; Hushmandi K Int J Biol Macromol; 2022 Dec; 222(Pt A):1151-1167. PubMed ID: 36191781 [TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic Targets. Shahcheraghi SH; Asl ER; Lotfi M; Ayatollahi J; Khaleghinejad SH; Aljabali AAA; Bakshi HA; El-Tanani M; Charbe NB; Serrano-Aroca Á; Mishra V; Mishra Y; Goyal R; Hromić-Jahjefendić A; Uversky VN; Lotfi M; Tambuwala MM CNS Neurol Disord Drug Targets; 2024; 23(10):1203-1216. PubMed ID: 38279763 [TBL] [Abstract][Full Text] [Related]
8. lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression. Siddique R; Thangavelu L; S R; Almalki WH; Kazmi I; Kumar A; Mahajan S; Kalra H; Alzarea SI; Pant K Pathol Res Pract; 2024 Jun; 258():155333. PubMed ID: 38723325 [TBL] [Abstract][Full Text] [Related]
9. Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer. Thapa R; Afzal O; Gupta G; Bhat AA; Almalki WH; Alzarea SI; Kazmi I; Altamimi ASA; Subramaniyan V; Thangavelu L; Singh SK; Dua K Pathol Res Pract; 2023 Sep; 249():154736. PubMed ID: 37579591 [TBL] [Abstract][Full Text] [Related]
10. Unravelling the role of long non-coding RNAs in modulating the Hedgehog pathway in cancer. Chandel SS; Mishra A; Dubey G; Singh RP; Singh M; Agarwal M; Chawra HS; Kukreti N Pathol Res Pract; 2024 Feb; 254():155156. PubMed ID: 38309021 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA in prostate, bladder, and kidney cancer. Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479 [TBL] [Abstract][Full Text] [Related]
12. Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer. Almalki WH Pathol Res Pract; 2023 Nov; 251():154852. PubMed ID: 37837857 [TBL] [Abstract][Full Text] [Related]
13. LncRNAs as Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy. Ray SK; Mukherjee S Curr Cancer Drug Targets; 2021; 21(5):416-427. PubMed ID: 33413062 [TBL] [Abstract][Full Text] [Related]
14. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Shi Q; Xue C; Zeng Y; Yuan X; Chu Q; Jiang S; Wang J; Zhang Y; Zhu D; Li L Signal Transduct Target Ther; 2024 May; 9(1):128. PubMed ID: 38797752 [TBL] [Abstract][Full Text] [Related]
15. The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer. Hjazi A; Obaid RF; Ali SS; Abdullaev B; Alsaab HO; Huldani H; Romero-Parra RM; Mustafa YF; Hussien BM; Saadoon SJ Pathol Res Pract; 2023 Aug; 248():154657. PubMed ID: 37451194 [TBL] [Abstract][Full Text] [Related]
16. Recent progress and the emerging role of lncRNAs in cancer drug resistance; focusing on signaling pathways. Saadh MJ; Rasulova I; Almoyad MAA; Kiasari BA; Ali RT; Rasheed T; Faisal A; Hussain F; Jawad MJ; Hani T; Sârbu I; Lakshmaiya N; Ciongradi CI Pathol Res Pract; 2024 Jan; 253():154999. PubMed ID: 38118218 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236 [TBL] [Abstract][Full Text] [Related]
18. LncRNAs and PTEN/PI3K signaling: A symphony of regulation in cancer biology. Almalki WH Pathol Res Pract; 2023 Sep; 249():154764. PubMed ID: 37643526 [TBL] [Abstract][Full Text] [Related]
19. Notch-associated microRNAs in cancer. Mo YY; Tang H; Miele L Curr Drug Targets; 2013 Sep; 14(10):1157-66. PubMed ID: 23834150 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway. Gao K; Ji Z; She K; Yang Q; Shao L Biomed Pharmacother; 2017 Mar; 87():555-560. PubMed ID: 28081466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]